Gary Slaughter, MD
Dermatology · Charlotte, NCNPI 1770522328
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Medimetriks Pharmaceuticals, Inc. at 24.6% of the total. Reporting peaked in 2019 at $13,540 and has fallen 72.2% since, to $3,759 in 2025. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,067 payments — averaging $51.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medimetriks Pharmaceuticals, Inc.$14K
- EPI Health, LLC$7K
- Pfizer$7K
- Incyte Corporation$6K
- Dermavant Sciences, Inc.$4K
- Sanofi$4K
- plus $14K from 29 others
What the payments were for
- Consulting fees$15,94229%
- Speaking & faculty fees$9,54017%
- Travel & lodging$1,8553%
- Food & beverage$27,42550%
- Education$890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | 248 | $13,515 |
| EPI Health, LLC | 58 | $6,788 |
| Pfizer | 110 | $6,571 |
| Incyte Corporation | 12 | $5,771 |
| Dermavant Sciences, Inc. | 85 | $4,432 |
| Sanofi | 59 | $3,594 |
| E.r. Squibb & Sons, L.L.C. | 91 | $2,487 |
| Sun Pharmaceutical Industries Inc. | 91 | $2,024 |
| AbbVie | 33 | $1,339 |
| Novartis | 40 | $1,016 |
| Amgen | 48 | $921 |
| LEO Pharma Inc. | 28 | $719 |
| Johnson & Johnson | 15 | $708 |
| Galderma Laboratories, L.p. | 31 | $699 |
| Regeneron Healthcare Solutions, Inc. | 13 | $672 |
| Janssen Scientific Affairs, LLC | 9 | $657 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 27 | $559 |
| UCB, Inc. | 7 | $536 |
| Organon | 7 | $296 |
| Sanofi-aventis U.S. LLC | 7 | $264 |
| Journey Medical Corporation | 9 | $256 |
| Arcutis Biotherapeutics, Inc. | 5 | $252 |
| Lilly USA, LLC | 4 | $142 |
| Almirall LLC | 6 | $140 |
| Dermira, Inc. | 1 | $123 |
| Mayne Pharma Commercial LLC | 8 | $97 |
| Bristol Myers Squibb | 4 | $89 |
| Sebela Pharmaceuticals Inc. | 3 | $50 |
| Sandoz | 2 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $20 |
| Botanix SB Inc | 1 | $17 |
| Organogenesis Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cloderm$6,210
- Rhofade$6,210
- Sitavig$5,831
- Minolira 105mg$5,831
- Minolira 135mg$5,831
- Neo-Synalar$5,755
- EUCRISA$5,250
- VTAMA$3,366
- LIBTAYO$1,804
- Tovet (emollient formulation)$1,400
- DUPIXENT$1,169
- Clindacin ETZ$1,154
- Sotyktu$940
- MINOLIRA EXTENDED RELEASE$758
- Tremfya$683
- ILUMYA$495
- WYNZORA$379
- Rinvoq$352
- Clodan$350
- Bimzelx$247
How this compares
$54,851 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 26 | $311,764 |
| Dupixent PenDupilumab | 18 | $69,635 |
| Clobetasol Propionate | 233 | $8,021 |
| Fluocinonide | 168 | $7,473 |
| Metronidazole | 45 | $2,845 |
| Triamcinolone Acetonide | 291 | $2,836 |
| Tretinoin | 48 | $2,800 |
| Cephalexin | 279 | $1,978 |
| Clindamycin Phosphate | 82 | $1,827 |
| Hydrocortisone | 216 | $1,414 |
| Minocycline Hcl | 79 | $1,166 |
| Desonide | 15 | $1,134 |
| Doxycycline Hyclate | 60 | $881 |
| Ketoconazole | 56 | $755 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 12 | $663 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Charlotte
- Patrick McElgunnCharlotte$565K
- Christopher SnyderCharlotte$24K
- Marc DarstCharlotte$19K
- Martie PriceCharlotte$15K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- George MagelHickory$554K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.